NCT03114020View on ClinicalTrials.gov

Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

November 12, 2019

Study Completion Date

November 12, 2019

Conditions

EmphysemaAlpha 1-Antitrypsin Deficiency

Interventions

DRUG

Hyaluronic Acid Inhalation Solution

twice a day 3 mL of 0.03% Hyaluronic Acid Inhalation Solution

DRUG

Placebo Inhalation Solution

Twice a day 3 ml of placebo inhalation solution

Trial Locations (6)

13066

Pulmonary Health Physicians, PC, Fayetteville

29425

Medical University of South Carolina, Charleston

33136

University of Miami Hospital, Miami

53226

Medical College of Wisconsin / Froedtert Hospital, Milwaukee

75708

University of Texas Health Science Center, Tyler

M5T 3A9

Inspiration Research Limited, Toronto

All Listed Sponsors

lead

Gerard Turino

INDIV

NCT03114020 - Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency | Biotech Hunter | Biotech Hunter